- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myelodysplastic Syndrome, Unclassified
Total 34320 results
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Associazione Qol-oneTerminatedMyelodysplastic SyndromesFrance, Italy, Greece
-
Helsinn Healthcare SACompletedMyelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsTerminated
-
Boehringer IngelheimTerminatedMyelodysplastic SyndromesJapan
-
Association pour la recherche sur les Affections...CompletedMyelodysplastic Syndromes
-
Larry Cripe, MDCelgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.; Walther Cancer InstituteTerminatedMyelodysplastic SyndromesUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnMyelodysplastic SyndromesUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Washington University School of MedicineCompletedMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Xian-Janssen Pharmaceutical Ltd.CompletedMyelodysplastic SyndromeChina
-
Janssen-Cilag International NVCompletedMyelodysplastic SyndromesFrance, Germany, Bulgaria, Greece, Russian Federation
-
Genzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromesUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedMyelodysplastic SyndromesSwitzerland
-
Eisai Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
PETHEMA FoundationRoche Pharma AG; Celgene CorporationTerminatedMyelodysplastic SyndromeSpain
-
Groupe Francophone des MyelodysplasiesGenzyme, a Sanofi CompanyCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
Janssen Pharmaceutical K.K.CompletedMyelodysplastic SyndromeJapan
-
Duke UniversityCelgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
Eisai Inc.CompletedMyelodysplastic SyndromeUnited States, Canada
-
Seoul National University HospitalCompletedMyelodysplastic SyndromesKorea, Republic of
-
European Organisation for Research and Treatment...WithdrawnMyelodysplastic SyndromesFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteTerminated
-
Basque Health ServiceUnknown
-
Cooperative Study Group A for HematologyUnknownMyelodysplastic SyndromeKorea, Republic of
-
AmgenCompletedMyelodysplastic Syndromes
-
Tel-Aviv Sourasky Medical CenterUnknownMyelodysplastic SyndromeIsrael
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
NovaceaUnknownMyelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Maria Sklodowska-Curie National Research Institute...KCRINot yet recruitingAcute Myeloid Leukemia Myelodysplastic SyndromesPoland
-
Hoffmann-La RocheTerminatedMyelodysplastic Syndromes, Myelogenous Leukemia, AcuteUnited States, Canada, Germany
-
National Cancer Institute (NCI)TerminatedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | de Novo Myelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
University of UlmTerminatedAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Germany
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
City of Hope Medical CenterCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | Adult Acute Myeloid Leukemia | de Novo Myelodysplastic SyndromesUnited States
-
Sunnybrook Health Sciences CentreNot yet recruitingMyelodysplastic Syndromes | MDSCanada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Actinium PharmaceuticalsCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Peking University People's HospitalUnknownLeukemia | Myelodysplastic SyndromeChina
-
Bristol-Myers SquibbRecruitingMyelodysplastic SyndromesCanada, United States, China, Australia, France, Greece, Hungary, Germany, Italy, Czechia, Poland, Mexico, Spain, Brazil, Colombia, India, Argentina, Puerto Rico
-
University Hospital, BordeauxNot yet recruitingMyelodysplastic Syndromes | FerroptosisFrance
-
Agios Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesIsrael, United States, Korea, Republic of, Australia, France, Germany, Spain, United Kingdom, Czechia, Austria, Italy, Greece, Poland